Absolutely. That's what the Association québécoise des pharmaciens propriétaires, the AQPP, is proposing.
Earlier I said I thought the system wasn't perfect. It's a mixed system; sometimes you have to pay out the full $1,000 ceiling amount if you're insured privately. There should be some protection against that.
Perhaps other, simpler measures should be adopted. We mentioned how hard it is to access exception status drugs, for example, where it's difficult because people don't have access to doctors. Sometimes it's an obstacle course for patients. The professions should be decompartmentalized so that other professions can provide access to those products. There are rumours that that's what's happening in Quebec.
Furthermore, Quebec's Institut national d'excellence en santé et en services sociaux, the INESSS, makes scientific decisions on what should and shouldn't be included in the formulary. As a pharmacist and scientist, I support those decisions in 99.9% of cases because they're based on effectiveness, efficiency and relevance rather than feelings of being deprived of a product or not having access to this or that.
We know the pharmaceutical industry works miracles, but is it always necessary to cover the thirtieth molecule, which costs more? The answer is no.
INESSS conducts those analyses, and I think that improves the quality of the Quebec system.